The private equity backers of Foundation Consumer Healthcare, the company behind the Plan B morning-after pill, are exploring a sale of the business, according to people familiar with the matter.
The company is being advised by Goldman Sachs and is considering a range of options, including a sale to a strategic buyer or a public offering, the people said.
Foundation Consumer Healthcare is owned by Kelso & Co. and Juggernaut Capital Partners, which acquired the company in 2017 for $675 million. The company also sells other over-the-counter healthcare products, such as Breathe Right nasal strips, Dimetapp cold and flu medicine, and Alavert allergy medication.
The sale of Foundation Consumer Healthcare would come at a time of growing interest in the women’s health market. The global market for women’s health products is expected to reach $650 billion by 2025, according to Grand View Research.
Plan B is the most popular morning-after pill in the United States. The drug is available without a prescription and can be taken up to 72 hours after unprotected sex.
A sale of Foundation Consumer Healthcare would likely draw interest from a number of potential buyers, including pharmaceutical companies, consumer goods companies, and private equity firms.
Here are some of the key takeaways;
- The private equity backers of Foundation Consumer Healthcare are exploring a sale of the business.
- The company is being advised by Goldman Sachs and is considering a range of options, including a sale to a strategic buyer or a public offering.
- Foundation Consumer Healthcare also sells other over-the-counter healthcare products, such as Breathe Right nasal strips, Dimetapp cold and flu medicine, and Alavert allergy medication.
- The sale of Foundation Consumer Healthcare would come at a time of growing interest in the women’s health market.
The sale of Foundation Consumer Healthcare would be a significant development for the women’s health market. The sale is likely to attract interest from a number of potential buyers, and it could lead to further consolidation in the market.
